Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients

Author(s):
Poppelaars, F.; Costa, M.G. da; Faria, B.; Berger, S.P.; Assa, S.; Daha, M.R. (0000-0002-0113-0750); Pestana, J.O.M.; Son, W.J. van; Franssen, C.F.M.; Seelen, M.A.
Published
2018
Publication type
Article / Letter to editor
complementkidneycardiovascular riskhemodialysisbiocompatibilityinnate immunityC1-inhibitor
Date issued
2018-09-13
Language
English
Is part of
Frontiers in Immunology
hdl
1887/86602
doi
10.3389/fimmu.2018.02070
URL
https://www.frontiersin.org/articles/10.3389/fimmu.2018.02070/full